Anthropic's new AI model, Claude Fable 5, is here. Early users see big improvements in handling complex tasks like software ...

Choosing a custom software development company is not just a procurement decision. For founders, CIOs, and product leaders ...

Autonomous agents are shortening project timelines and changing how people work in the sector, reports Avik Das ...

And they just kind of iterated their way to something that was marginally feasible.” The first few hundred years of inventing ...

For more than 50 years, U.S. academic medical centers (AMCs) have been the global engine for pharmaceutical innovation. These university-affiliated hospitals are dedicated to fulfilling the mission ...

Claude Opus 4.7 is the latest generally available version of Anthropic’s main AI model with a focus on advanced software development. Opus 4.7 is a notable improvement on Opus 4.6 in advanced software ...

Colin is an Associate Editor focused on tech and financial news. He has more than three years of experience editing, proofreading, and fact-checking content on current financial events and politics.

Selloff spills beyond US, drags down European names Wall Street rethinks one of its favorite trades Private credit stress sours sentiment further April 9 (Reuters) - U.S. software shares tumbled on ...

Anthropic on Tuesday released a preview of its new frontier model, Mythos, which it says will be used by a small coterie of partner organizations for cybersecurity work. In a previously leaked memo, ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Birgitta Böckeler, Distinguished Engineer at ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Iterative Health, a healthcare technology and services company powering the acceleration of clinical research, today announced the publication of scientific research ...

New AI tools from Anthropic sparked a broad sell-off in software and data stocks. Executives say fears are overblown, but analysts warn of margin and pricing pressure. Investors are reassessing which ...